Kala Pharmaceuticals Inc. buy Oppenheimer Holdings Inc.
Start price
02.06.25
/
50%
€3.07
Target price
02.06.26
€13.19
Performance (%)
-81.14%
Price
12.12.25
€0.56
Summary
This prediction is currently active. Massive losses of -81.14% have been the result for the BUY prediction by Oppenheimer_Holdings. This prediction currently runs until 02.06.26. The prediction end date can be changed by Oppenheimer_Holdings at any time. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Kala Pharmaceuticals Inc. | -25.821% | -25.821% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Kala Pharmaceuticals diskutieren
KALA BIO, Inc. (NASDAQ: KALA) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $15.00 price target on the stock.
Ratings data for KALA provided by MarketBeat
Stopped prediction by Oppenheimer_Holdings for Kala Pharmaceuticals Inc.
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.52
11.09.25
11.09.25
€28.21
11.09.26
11.09.26
-95.71%
12.12.25
12.12.25
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.39
19.08.24
19.08.24
€13.55
19.08.25
19.08.25
28.32%
20.08.25
20.08.25
Kala Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.29
01.04.24
01.04.24
€13.96
01.04.25
01.04.25
-32.11%
02.04.25
02.04.25